Kite Pharma, Inc. Proceeds from Common Stock Issued
Kite Pharma, Inc. reported Proceeds from Common Stock Issued of $399.68 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2017-08-08
- Kite Pharma, Inc. proceeds from issuance of common stock for the quarter ending 2017-06-30 was -$187.00K.
- Kite Pharma, Inc. proceeds from issuance of common stock for the quarter ending 2017-03-31 was $399.87M.
- Kite Pharma, Inc. proceeds from issuance of common stock for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Kite Pharma, Inc. proceeds from issuance of common stock for the quarter ending 2016-09-30 was $0.00.
- Kite Pharma, Inc. proceeds from issuance of common stock for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Kite Pharma, Inc. proceeds from issuance of common stock for fiscal 2015 was $300.72M, a 10.18% decline from fiscal 2014.
- Kite Pharma, Inc. proceeds from issuance of common stock for fiscal 2014 was $334.81M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$187.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $399.68M 10-Q · filed 2017-08-08 | $399.68M derived: sum of 3 quarters · filed 2017-08-08 | $399.68M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $399.87M 10-Q · filed 2017-05-08 | $399.87M derived: sum of 2 quarters · filed 2017-05-08 | $399.87M derived: sum of 3 quarters · filed 2017-05-08 | $399.87M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-08-08 | $0.00 10-K · filed 2017-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | $0.00 10-Q · filed 2016-11-09 | $274.06M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | $274.06M derived: sum of 3 quarters · filed 2017-08-08 | $274.06M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | $274.06M derived: sum of 2 quarters · filed 2017-05-08 | $274.06M derived: sum of 3 quarters · filed 2017-05-08 | $274.06M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $274.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $274.06M derived: sum of 2 quarters · filed 2017-02-28 | $274.06M derived: sum of 3 quarters · filed 2017-02-28 | $300.72M 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $26.66M 10-Q · filed 2016-11-09 | $214.85M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $26.66M 10-Q · filed 2016-08-08 | $214.85M derived: sum of 3 quarters · filed 2017-02-28 | $214.85M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $26.66M 10-Q · filed 2016-05-09 | $214.85M derived: sum of 2 quarters · filed 2017-02-28 | $214.85M derived: sum of 3 quarters · filed 2017-02-28 | |
| 2014-12-31 | $188.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $188.19M derived: sum of 2 quarters · filed 2017-02-28 | $334.81M 10-K · filed 2017-02-28 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $146.63M 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $146.63M 10-Q · filed 2015-08-10 |